BioMarin Presents New Data Advancing Understanding of Achondroplasia and Hypochondroplasia Treatment at the American Society for Bone and Mineral Research Annual Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 55.52 -0.92 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.44 | 52 Week High | $108.96 | |||
| Open | $56.40 | 52 Week Low | $62.12 | |||
| Day High | $57.00 | P/E | N/A | |||
| Day Low | $55.51 | EPS | $-1.27 | |||
| Volume | 1,212,647 | |||||
